Detalhe da pesquisa
1.
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older.
Pancreatology
; 20(3): 501-504, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31932214
2.
Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes.
Ann Surg
; 269(4): 663-670, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29334555
3.
Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy.
Ann Surg Oncol
; 26(5): 1394-1400, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30680477
4.
Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal Adenocarcinoma.
Ann Surg
; 268(2): 289-295, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28628563
5.
Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.
Ann Surg Oncol
; 25(6): 1598-1607, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29569125
6.
Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 45(10): 1742-1751, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29663014
7.
Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma.
Ann Surg Oncol
; 24(11): 3338-3344, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28799004
8.
The value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma.
Eur J Nucl Med Mol Imaging
; 44(1): 71-80, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27511188
9.
Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.
Cancer
; 122(6): 917-28, 2016 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26716915
10.
Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy.
Ann Surg Oncol
; 23(1): 156-62, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26059652
11.
Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma.
BMC Cancer
; 15: 1095, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25777421
12.
Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX.
Pancreas
; 48(6): 837-843, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31210666
13.
A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal Junction.
Am J Clin Oncol
; 41(4): 321-325, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-26908161
14.
Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival.
J Gastrointest Surg
; 11(11): 1498-504; discussion 1504-5, 2007 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-17849166
15.
Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiation.
J Pain Symptom Manage
; 34(3): 244-52, 2007 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-17513082
16.
Recursive Partitioning Analysis Identifies Pretreatment Risk Groups for the Utility of Induction Chemotherapy Before Definitive Chemoradiation Therapy in Esophageal Cancer.
Int J Radiat Oncol Biol Phys
; 99(2): 407-416, 2017 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28871991
17.
18F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma.
J Nucl Med
; 58(11): 1756-1763, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28522744
18.
A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer.
J Thorac Oncol
; 12(6): 1001-1010, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28351804
19.
Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study.
Adv Radiat Oncol
; 2(3): 316-324, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29114598
20.
Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer.
Am J Clin Oncol
; 39(3): 228-35, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-24710122